Michael Gelband’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-367,195
Closed -$21.5M 1606
2026
Q1
$21.5M Buy
367,195
+90,778
+33% +$5.37M 0.17% 85
2025
Q4
$15.7M Buy
+276,417
New +$15.1M 0.12% 145
2024
Q1
Sell
-9,439
Closed -$276K 1508
2023
Q4
$276K Buy
+9,439
New +$287K ﹤0.01% 1202
2023
Q3
Sell
-20,332
Closed -$675K 1727
2023
Q2
$675K Buy
+20,332
New +$695K 0.01% 1245
2022
Q1
Sell
-28,559
Closed -$1.07M 2216
2021
Q4
$1.07M Buy
+28,559
New +$1.01M 0.01% 1036
2021
Q3
Sell
-7,723
Closed -$304K 2142
2021
Q2
$304K Sell
7,723
-17,185
-69% -$673K ﹤0.01% 1734
2021
Q1
$965K Sell
24,908
-4,140
-14% -$156K 0.01% 934
2020
Q4
$1.09M Buy
+29,048
New +$1.04M 0.01% 804
2019
Q2
Sell
-10,192
Closed -$425K 1114
2019
Q1
$425K Buy
+10,192
New +$371K 0.03% 373

Other funds holding BTI

Michael Gelband's BTI Position: Q2 2026 in Review

Michael Gelband sold out of British American Tobacco (BTI) in Q2 2026, closing a stake of 367,195 shares — an estimated $21.5M sold.

Michael Gelband first reported a position in BTI in Q1 2019 and held it in 9 quarters. The position peaked at $21.5M in Q1 2026. 903 funds tracked by Wall St. Rank hold BTI as of Q2 2026.

  • Michael Gelband reported no remaining British American Tobacco position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 367,195 British American Tobacco shares in Q2 2026, an estimated $21.5M.
  • Michael Gelband first reported a position in British American Tobacco in Q1 2019 and held it in 9 quarters.
  • Michael Gelband's British American Tobacco position peaked at $21.5M in Q1 2026.
  • 903 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.